Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial
经动脉化疗栓塞联合卡瑞利珠单抗和利沃西拉尼治疗不可切除的肝细胞癌(CHANCE2005/CARES-005):一项随机II期试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-01796
Zhu, Hai-Dong; Fan, Wei-Jun; Zhao, Chang; Wang, Song; Li, Yu-Liang; Jin, Zhi-Cheng; Zhang, Zhe-Wei; Guo, Jin-He; Cheng, Hong-Tao; Zhang, Qi; Lu, Jian; Zeng, Yong-Yi; Lv, Wei-Fu; Xu, Hao; Shao, Hai-Bo; Xu, Wei-Guo; Zhao, Xu-Ya; Gu, Shan-Zhi; Lin, Hai-Lan; Zheng, Wen-Heng; Piao, Long-Zhen; Song, Yu-Sheng; Zhao, Jian-Bo; Wang, Yuan-Cheng; Hou, Zhi-Guo; Sun, Ying; Guan, Ni; Huang, Ming; Yang, Wei-Zhu; Ji, Jian-Song; Teng, Gao-Jun